The aim of this study was to analyze in families with SLE for the presence of linkage and the structure and transmission of haplotypes containing alleles for the low-affinity Fcg receptors. The Fcg receptor polymorphisms FcgRIIA-131R/H, FcgRIIIA-176F/V and FcgRIIIB-NA1/2 and a polymorphism in the FcgRIIB gene were genotyped with RFLP, allele-specific PCR or pyrosequencing. Individual SNPs and haplotypes were tested for linkage in multicase families and for association using contingency tables, transmission disequilibrium test and affected family-based control groups in Swedish and Mexican singlecase families. No linkage or association could be detected using the FcgR polymorphisms in the multicase families. However, an association was found for both FcgRIIA-131R and IIIA-176F alleles in the single-case families, but not for IIIB or IIB. Allelic association to SLE was found for a haplotype that included both risk alleles, but not in haplotypes where only one or the other was present. We propose that FcgRIIA-131R and FcgRIIIA-176F are both risk alleles for SLE transmitted primarily, but not exclusively on a single major haplotype that behaves functionally in a situation similar to that of compound heterozygozity.
Introduction
SLE is a complex disease where environmental factors seem to gravitate on several genetic ones, none of which is fully penetrant. Family and twin studies have shown that the genetic component in SLE is important, further evidenced by the fact that SLE is one of the few autoimmune diseases for which there are mouse models that develop the disease spontaneously. 1 Among the regions that have been identified through genetic linkage analysis is 1q23, where the genes coding for the low-affinity Fcg receptors are located.
Humans have five low-affinity FcgR genes, IIA, IIB, IIC, IIIA and IIIB. A number of polymorphisms have been described within coding sequences of FcgRIIA, IIIA, IIB and IIIB. The polymorphisms identified have all very suggestive effects in the function of the molecules that bear them. The FcgRIIA polymorphism 131HoR and FcgRIIIA-176VoF have been suggested to alter the ligand affinity and receptor-mediated effector function, [2] [3] [4] [5] [6] [7] [8] while the FcgRIIB-232IoT polymorphism has been suggested to alter the inhibitory function of the FcgRIIB. The NA polymorphism of FcgRIIIB, in turn, appears to modify neutrophil phagocytosis. 9 The FcgRIIC gene has long been considered a pseudogene and no disease-associated polymorphisms have been described for it. Numerous studies have identified a genetic association between any one of these polymorphisms and SLE. Some studies have identified an association with the FcgRIIIA-176F allele or the FcgRIIA-131R allele for these polymorphisms. One study has found a weak association with the allele for threonine (T) of the FcgRIIB polymorphism in Japanese 10 and two other studies have shown an association with FcgRIIIB-NA2 in Japanese and Spanish populations. 10, 11 To our knowledge, only two studies have attempted the reconstruction of haplotypes of the FcgR alleles in SLE patients. In one, the construction of the haplotypes was carried out by estimation from genotype data. The authors concluded that susceptibility to SLE was contributed independently by both FcgRIIA and FcgRIIIA, in spite of the observation that the frequency of a haplotype containing FcgRIIA-131R and FcgRIIIA-176F was increased in SLE patients compared to healthy controls. 12 A second study found an association to the 131R-176F haplotype and strong linkage disequilibrium (LD) between the risk alleles of FcgRIIA and FcgRIIIA, but still concluded that FcgRIIIA was the susceptibility factor for SLE because the association with the haplotype was not stronger than with the alleles individually. In particular, the allelic association was strongest with FcgRIIIA-176F. 13 However, the difference in association between FcgRIIA-131R and FcgRIIIA-176F was not significant. Importantly, many of the studies having reported the association with FcgRIIA have reported a recessive association to the homozygous genotype (131RR) rather than to the allele itself, and the aforementioned attempts to compare the strength of allelic association between FcgRIIIA and FcgRIIA may therefore be inappropriate. Weaker allelic association with FcgRIIA does not discard this gene as a susceptibility factor.
In this study, we propose a unifying hypothesis that attempts to explain the varying results of the associations to the polymorphisms of FcgRIIA-131R and FcgRIIIA-176F in SLE in support of a role of both as risk alleles for SLE through the predominant, although not exclusive transmission of a unique haplotype containing both risk alleles.
Results
Linkage analysis with multicase families Using parametric linkage analysis on a set of 87 multicase families from various nationalities, we previously showed suggestive linkage to a 14 cM region at 1q23, including the FcgR locus. 14 The same family material was genotyped for the FcgR polymorphisms. Weak linkage was found for the FcgRIIIA locus and a marker using haplotypes with alleles from IIA and IIIA (Table 1) . However, no linkage to any of the other loci could be observed. When multipoint analysis was performed, the linkage disappeared (Table 1 ). Association was also tested in the multicase families using transmission disequilibrium test (TDT) and HRR (see Materials and methods section). No association could be found in the multicase families (data not shown).
Association analysis of the FccR polymorphisms in single-case families As numerous studies have shown association with FcgR alleles, we genotyped two sets of single-case families, originating from two different populations. We first compared the allele frequencies of the polymorphisms in parental chromosomes as well as in a set of population controls. We also identified the genotype frequencies for FcgRIIA and FcgRIIIA in these groups. The results are shown in Table 2 . Owing to gene duplication, the number of FcgRIIIB alleles in an individual varies between one and three, 15 and this makes it inappropriate to use PCR-based methods for determining the genotype frequencies for FcgRIIIB, 16 and we therefore only show the presence of the FcgRIIIB-NA2 allele in the result (see Tables 2 and 4) . Furthermore, the presence of the FcgRIIIB null allele was not determined and therefore the frequencies of NA2 should be considered as carrier frequencies and taken with caution.
No significant difference in allele or genotype frequencies for FcgRIIA or FcgRIIIA was observed in the alleles of parents of Mexican and Swedish individuals with SLE or in the population controls. In contrast, there was a Table 4 ). We therefore considered the difference in frequency in FcgRIIIB and IIB.3 as irrelevant for further analyses and since there were no differences in frequencies in FcgRIIA and FcgRIIIA, we decided to join both sets of families for the haplotype analyses and transmission tests. The analysis of the combined single-case family set showed association with SLE for both FcgRIIA-131R (P ¼ 0.01, odds ratio (OR): 1.5) and FcgRIIIA-176F (P ¼ 0.005, OR: 1.8) when compared to affected family-based controls (AFBACs) (see Table 3 ). Even though the Mexican families contributed most to the association, this was not greatly modified by the inclusion of the Swedish families.
We also tested the presence of association in a group of Swedish sporadic patients against a population control set and the AFBAC group (see Table 4 ). We found allelic association between SLE and FcgRIIIA-176F (P ¼ 0.03 against population controls), but no association between SLE and the FcgRIIA-131R allele. However, we did find a significant association with SLE with the FcgRIIA-131R/ R and the FcgRIIIA-176F/F genotypes (P ¼ 0.03 and 0.01, respectively).
In order to evaluate the strength of the effect of the individual polymorphisms and their independency, the association of the FcgRIIA-131R and FcgRIIIA-176F to SLE was tested using a two-locus method. The results are shown in Table 5 . Interestingly, each locus (FcgRIIA and FcgRIIIA) showed individual association even after stratifying for the possible confounding effect of the other loci (tests 1 and 2, OR: 2.3, P ¼ 0.03 and OR: 2.0, P ¼ 0.02, respectively). The combined association test for FcgRIIA-131R and FcgRIIIA-176F gave the highest risk of developing lupus (test 3, OR: 2.8, confidence interval (CI): 1.6-4.8, P ¼ 0.0002) than for FcgRIIA or FcgRIIIA individually, suggesting the possibility of an additive effect. However, this difference is not statistically significant since the 95% CI for the combined test and for each individual test is overlapping.
In order to test haplotype transmission of FcgRIIA, IIIA, IIB and IIIB alleles, haplotypes were constructed for two, three or four polymorphisms using all single-case families (see Tables 6a-c) . We analyzed haplotype transmission from parents to SLE patients using AFBAC and TDT. Of all possible haplotypes identified using three or four polymorphisms (3-SNP and 4-SNP haplotypes, respectively), only one of the haplotypes containing both the FcgRIIA and FcgRIIIA risk alleles (211 and 2111, respectively) showed an increased frequency of transmission to patients in single-case families (31% transmitted versus 20% untransmitted, P ¼ 0.02, OR ¼ 1.8 and 28%; transmitted versus 17% untransmitted in all families, P ¼ 0.02, OR ¼ 1.9, respectively) with significance comparable to that of the risk alleles separately. Other haplotypes containing risk alleles for FcgRIIA and FcgRIIIA individually were not associated with SLE Interestingly, we observed a strong protective association with one particular haplotype in the families having the alleles for FcgRIIA-131H and FcgRIIIA-176V (of all haplotypes, only the protective one is shown in Tables 6a-c). This also supports the notion that the combined effect of both genes transmitted in a single haplotype influences susceptibility to and protection against SLE.
Discussion
Previously, a susceptibility region at 1q23, where the FcgR-locus is located, was identified in a set of multi case families. The aim of this study was to use known FcgR polymorphisms and to analyze linkage in the original set of multicase families, as well as to test for an association in a new set of single-case families.
We did not find evidence of linkage in the original set of multicase families to any of the FcgR polymorphisms. There was a weak nonsignificant linkage (Z ¼ 1.6) for the FcgRIIIA locus. However, the lack of linkage to other adjacent loci and the important decrease in linkage in the multipoint analysis indicate that this weak linkage may be a false signal.
Another explanation for the lack of linkage is that the FcgR polymorphisms are much less informative than microsatellite markers (PIC values where 0.30-0.37 compared to 0.71 for markers detecting the susceptibility region in the first place), reducing the number of informative meioses in the families. However, a haplotype constructed by alleles from FcgRIIA and FcgRIIIA increased the PIC value (E0.60), but did not increase the linkage.
The lack of linkage in our multicase families does not rule out that the FcgR genes contribute to the susceptibility for SLE in sporadic cases. We did identify an association in the set of single-case families. Using real family data, we show that risk alleles of the Fcg receptors with low affinity for IgG are predominantly inherited on one haplotype associated with SLE.
Zuniga et al 12 had suggested using estimated haplotypes that FcgRIIIA was independent of IIA and vice versa. Edberg et al 13 showed the presence of an association with a haplotype, but because this haplotype had no stronger effect than for each of the risk alleles alone, dependency between risk alleles was discarded. Furthermore, the authors proposed that FcgRIIIA-F was the sole independent risk allele for SLE because they observed a stronger allelic association with FcgRIIIA than with FcgRIIA in a set of cases and controls.
We have reasoned that the findings described do not rule out FcgRIIA-131R or FcgRIIIA-176F as risk alleles for SLE. Based on our data and those published, 12, 13 we propose that both FcgRIIA-131R and FcgRIIIA-176F are risk alleles for SLE. The presence of a single haplotype containing both risk alleles and the frequent observation of the recessive inheritance of FcgRIIA-131R [17] [18] [19] [20] provide information to propose a unifying explanation for the results observed. We did observe a slight transmission distortion for other haplotypes containing the risk alleles of FcgRIIA-131R and FcgRIIIA-176F, but this was regardless of other alleles in IIB or IIIB, supporting that both risk alleles for IIA and IIIA have to be present.
We can visualize three situations in which the risk alleles for SLE may be found (which are schematized in Figure 1 ) ordered in importance as to the risk for SLE they contribute with. These situations have evolved as a result of population history, genetic drift or admixture, but the main situation of a risk haplotype has prevailed probably because of selection.
This first situation (Figure 1a) , which is the most frequent one, is when both risk alleles for FcgRIIA-131R and FcgRIIIA-176F are present and transmitted on the same haplotype. The haplotype may also be found in the homozygous form in some individuals or with a haplotype in the other chromosome having FcgRIIIA-176F but not FcgRIIA-131R. As FcgRIIIA-176F is the most frequent allele (70% in population controls), it has the highest probability of being found in different haplotype combinations. Functionally this situation is similar to compound heterozygosity, where both risk alleles are required to reach a threshold effect.
In the second situation, possibly mostly found in some populations (as the Swedish), but not in others, FcgRIIA-131R is found in homozygosity. Owing to the high allele frequency in the population and selection towards the haplotype, the FcgRIIIA-176F allele will often be found together with FcgRIIA-131R in at least one of the chromosomes (the same haplotype as above), increasing the risk. This increase is reflected as a trend towards an additive effect. Consequently, there will be an increase of the allelic association for FcgRIIIA that is observed in several studies, while the allelic association of FcgRIIA remains low.
The third situation represents a real compound heterozygote found in the least of the cases, where FcgRIIA-131R and FcgRIIIA-176F are found in different haplotypes, but both are required functionally to reach a threshold effect. Once again, an allelic association with FcgRIIA-131R alone is rare because FcgRIIA does not confer a dominant risk for SLE. The presence of the FcgRIIIA-176F contributes to the allelic association of this risk allele.
Risk with both alleles together on the same haplotype may be difficult to detect as it does not necessarily have to be statistically 'stronger' than for each allele alone, because both are transmitted on the same haplotype. This may be considered as a confounding effect and in complex diseases a situation difficult to distinguish from those where a single polymorphism is involved in disease susceptibility. As mentioned, no additive effect, or a small additive effect is found, in particular, for the cases in the second situation (Figure 1b) . We can rule out that the effect observed is due to LD with FcgRIIB. We did not detect association with the 232I/T SNP in a casecontrol study performed on a Swedish population 21 or a novel polymorphism (FcgRIIB.3). However, we cannot rule out an effect from FcgRIIC.
Our hypothesis explains the apparently controversial results that have been described through the years with regard to the susceptibility effect of these two gene alleles. Both genes have largely a similar function as lowaffinity binders for the Fc portion of IgGs, but with differences in affinity depending on the isotype and various expression patterns. The human has duplicated the FcgR genes through positive selection, possibly as a result of these genes' different affinities for the various IgG isotypes. This may be important in relation to an immune response against infection. Interestingly, and we believe, supportive of our proposal is the fact that we also find one single haplotype protective against SLE.
In conclusion, we propose a unifying hypothesis where alleles for both FcgRIIA and FcgRIIIA are risk factors for SLE. Furthermore, there is a trend that risk is provided by the presence of both risk alleles on one single haplotype that has prevailed in the SLE population. The protective haplotype confers, in turn, a selective advantage. A haplotype meta-analysis would need to be performed in order to verify this hypothesis conclusively.
Material and methods

Families, patients and controls
In all, 87 multicase families from various population groups were used and have been described previously. Haplotype analysis of the FccR in SLE families V Magnusson et al were used in the FcgR SNPs analysis. Patients were considered as having SLE by fulfilling four or more of the 1982 ACR criteria. 22 A group of sporadic SLE cases of Swedish descent, without available parents (n ¼ 216), was also included under the same criteria and population controls from Sweden were used (n ¼ 229).
Genotyping of the FccR polymorphisms
The FcgRIIIA-176 V/F was genotyped using pyrosequencing. The accession number for the genomic sequence used for primer design was AC013307 (Genbank). Genomic DNA was first amplified using nested PCR in an outer reaction volume of 15 ml with 10 ng of genomic DNA, 1.5 mM MgCl, 1.25 pmol per primer and 0.3 U of Platinum s Taq DNA polymerase (Roche Molecular systems, Inc., Ca, USA). The PCR conditions were: 941C for 1 min, 651C for 40 s and 721C for 2 min for 35 cycles, using the following sense primer: 5 0 -CTCTGCACTGA GAGCTGAGGC and antisense primer 5 0 -GGTCAGAT GGTTAATTAGCTGCAG. One of the inner primers was biotinylated at the 5 0 -end to allow for immobilization; the inner PCR mixture consisted of 1.5 mM MgCl, 1.0 pmol per primer and 0.8 U of Platinum s Taq DNA polymerase (Roche Molecular systems) in a total volume of 50 ml. The PCR conditions for the inner primers was carried out as follows: 941C for 1 min, 64.51C for 40 s and 721C for 2 min for 35 cycles, using sense primer 5 0 -GTCACATATTTA CAGAATGGCAAAGG and antisense primer 5 0 -GATTG CAGGTTCCACACACAGGC. Sample preparation and annealing of PCR products were performed on an MBS automated workstation (MBS Stockholm, Sweden) using streptavidin-coated beads following the manufacturer's instructions (MBS). Pyrosequencing (Pyrosequencing Uppsala, Sweden) was performed according to the manufacturer's instructions using the sequencing primer, 5 0 -CTACTTCTGCAGGGGGCTT. The genotypes were verified by direct sequencing.
FcgRIIA-131R/H genotyping was performed using an allele-specific restriction enzyme digestion with BstUI (New England Biolabs, Beverly, MA, USA) as described previously, with minor modifications. 23 The polymorphism of FcgRIIIB was determined by gene-and allele-specific PCR using a protocol according to Hessner et al. 24 FcgRIIB.3 is a novel SNP located in the 3 0 -UTR of the FcgRIIB gene (FcgRIIB.3-A/G), 193 bp downstream of the stop codon, which was identified by in silico search in the dbSNP (reference SNP Id: rs12721). This SNP was genotyped using pyrosequencing. The accession number of the genomic sequence used for primer design was M90735. Genomic DNA was first amplified using nested PCR in an outer reaction volume of 15 ml with 10 ng of genomic DNA, 1.5 mM MgCl, 1.25 pmol per primer and 0.3 U of Platinum s Taq DNA polymerase (Roche Molecular Systems, Inc., CA, USA). The outer PCR conditions were: 941C for 1 min, 631C for 40 s and 721C for 2 min for 35 cycles, using the outer primers; sense primer: 5 0 -GGGAGATGCTGCAGTTCCAAAAGA; antisense: 5 0 -CTAACCTGTAACATAAGCATTTCCCA. One of the inner primers was biotinylated at the 5 0 -end to allow for immobilization; the inner PCR mixture consisted of 1.5 mM MgCl 2 , 1.0 pmol per primer and 0.8 U of Platinum s Taq DNA polymerase (Roche Molecular systems) in a total volume of 50 ml. The inner PCR was performed as follows: 941C for 1 min, 601C for 40 s and 721C for 2 min for 35 cycles, using the following sense primer: CTTCCAGAGTCATCTACCTGAGTC; and antisense primer: 5 0 -GGATGTGGAACGGAAGAGCCTTG (biotinylated). For pyrosequencing, sample preparation and annealing of PCR products were performed as described above. The sequencing primer used was: 5 0 -CACAGA CAATATGGTCCCAAA. The genotypes were verified by sequencing.
The FcgRIIB-232IoT polymorphism 10 was genotyped in a set of Swedish patients and controls, but details will be presented elsewhere. 21 To control the genotyping data, some individuals were genotyped more than once and the transmission of alleles within families was checked for Mendelian errors. All SNPs were also found to be in Hardy-Weinberg equilibrium.
Statistical analysis
For linkage analysis, the ANALYZE software package, version 2.1, 25 and the FASTLINK software package, version 4.0P 26, 27 were used for parametric and nonparametric analyses. The test models for the parametric analysis have been previously described in detail. 14 For association analysis, the FcgR polymorphisms were analyzed using AFBACs as reported previously, 28 where the control groups consist of truly nevertransmitted-to-the-patients parental chromosomes in the single-case families and is optimal for admixed populations. The TDT was also used. No transmission distortion of the different FcgR alleles in nonaffected sibs in multi-and single-case families was found. w 2 analyses in 2 Â 2 contingency tables were used in the association analysis and OR were calculated with 95% CIs.
To investigate the independence of associated FcgR polymorphisms, a two-locus method described by Svejgaard and Ryder 29 was used. OR were calculated by Haldane's modification of Woolf's method 30, 31 and the significance was evaluated using Fisher's exact test. Haplotypes were extracted using GENEHUNTER, version 2.1. 
